T. Rowe Price Investment Management, Inc. Prometheus Biosciences, Inc. Transaction History

T. Rowe Price Investment Management, Inc.

  • $166 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$103.46 - $126.29 $358,695 - $437,847
3,467 Added 0.4%
868,006 $93.2 Million
Q4 2022

Feb 14, 2023
BUY
$36.06 - $117.21 $16.5 Million - $53.6 Million
457,288 Added 112.29%
864,539 $95.1 Million
Q3 2022

Nov 14, 2022
BUY
$28.17 - $59.01 $11.5 Million - $24 Million
407,251 New
407,251 $24 Million

Others Institutions Holding RXDX

# of Institutions
2
Shares Held
29.6K
Call Options Held
0
Put Options Held
0
View Full List

About Prometheus Biosciences, Inc.

RXDX Quotes by TradingView
  • Ticker RXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,904,100
  • Description
  • Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...
More about RXDX
Track This Portfolio

Track T. Rowe Price Investment Management, Inc. Portfolio

Follow T. Rowe Price Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email